Article Information
History
- January 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xiaolong Tiana,
- Cheng Lia,
- Ailing Huanga,
- Shuai Xiaa,
- Sicong Lua,
- Zhengli Shic,
- Lu Lua,
- Shibo Jianga,
- Zhenlin Yangb,*,
- Yanling Wua,* and
- Tianlei Yinga,*
- aMOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China
- bDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
- cCAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
- ↵*Correspondence: Tianlei Ying (tlying{at}fudan.edu.cn), Yanling Wu (yanlingwu{at}fudan.edu.cn), or Zhenlin Yang (yang_zhenlin{at}fudan.edu.cn), Room 504, Fosun Building, 131 Dong-an Road, Shanghai 200032, China, Tel: 86-21-54237761
Posted January 28, 2020.
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
